Borderline Resectable Pancreatic Cancer

Explore clinical trials studying Borderline Resectable Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Borderline Resectable Pancreatic Cancer trial results

Recruiting

NCT06944587

Conditions: Borderline Resectable Pancreatic Cancer, Chemotherapy Effect, Locally Advanced Pancreatic Cancer, +1 more
Locations: Haukeland University Hospital Bergen, Norway

Stavanger University Hospital Stavanger, Norway

University Hospital of North Norway Tromsø, Norway

St. Olavs Hospital, Trondheim University Hospital Trondheim, Norway

Not Yet Recruiting

NCT07325214

Conditions: Borderline Resectable Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

University of Texas Health Science Center at San Antonio San Antonio, Texas, United States

University of Virginia Medical Center Charlottesville, Virginia, United States

Seoul National University Bundang Hospital, Gyeonggi-do, South Korea

Not Yet Recruiting

NCT07477418

Conditions: Borderline Resectable Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: University of Vermont Medical Center Burlington, Vermont, United States

Not Yet Recruiting

NCT07448376

Conditions: Borderline Resectable Pancreatic Cancer, CTCs, Digestive System Diseases, +18 more
Locations: Tongji Hospital, Tongji Medical College, HUST Wuhan, Hubei, China